Stocks: Page 2
Freshworks Founder Girish Mathrubootham Sells $40M in Shares Amid Strategic Shifts
For the July-September quarter, the company reported a 22 per cent year-over-year increase in revenue, reaching $186.6 million. For the full fiscal year, Freshworks projects a 20 per cent growth, with total revenue estimated to range between $713 million and $716.6 million.
Opal Fuels CEO on Steering the Future of Renewable Natural Gas
Opal Fuels' vertically integrated RNG model positions the company for substantial long-term growth in the growing renewable energy market.
MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
Most cryptocurrency traders have focused on MicroStrategy stock lately, with the latest trends suggesting it'll be added to the NASDAQ 100.
Cintas Shares Slide: A Prime Opportunity to Buy the Dip
Dividend-paying Cintas is on sale, with shares near a multi-month low, likely to rebound soon because of analysts and institutional support.
Palantir’s Momentum Persists Despite Market Worries
After shrugging off the Fed-induced correction, Palantir's earnings report will be the next opportunity for the bulls or bears to be proven right
3 High-Dividend Utility Stocks for Reliable Income
As the utility market experiences rapid growth, fueled by rising energy demand and technological advancements, fundamentally solid utility stocks such as ONEOK (OKE), FirstEnergy (FE), and UGI Corporation (UGI) are...
Micron Stock Under $100: Seize the AI-Driven Upside
Micron's leadership position in data center/AI memory is established with its HBM3E chips surpassing the competition in performance, capacity, and energy use.
SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
For for those of us who are looking at SolarEdge with a fresh pair of eyes, there are a few reasons to be excited, albeit cautiously.
3 Financial Stocks Offering Stability and Growth
As the financial services industry embraces digital transformation, fundamentally robust stocks CPI Card Group (PMTS), Regional Management (RM), and UBS Group (UBS) are positioned to capitalize on emerging trends and...
Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
Novo Nordisk A/S is moving closer to adding more sales for its blockbuster GLP-1 drug semaglutide to treat a chronic liver disease.
Why Now Is the Ultimate Time to Invest in Oil Stocks
As value stocks underperform growth stocks the most over a multi-year period, oil stocks might become a potential buy in the coming months.
Is the Stock Market in a Rolling Correction?
Are you impressed by the S&P 500 (SPY) staying above 6,000? You shouldn't be because of the "rolling correction" taking place. Steve Reitmeister explains what that is...and how to trade...
Make Money Anywhere — The Reality of Day Trading on the Road
You really can travel and trade — but only after you pay the price.
AppLovin Insiders Sell Shares: Stock Price Indicated Higher
AppLovin got the analyst's attention with Q3 earnings. Insiders are selling the stock, but why not? It's been up as much as 1000%, offering a timely exit.
Salesforce's Clear Path to $400 and Beyond
Given how well its fundamental performance is trending in the right direction, it’s no surprise that Salesforce shares have been moving higher.